There is clear evidence that elevated Lp(a) is a causal risk factor for ASCVD, CAVD, and cardiovascular and all-cause mortality in both genders and multiple ethnic groups. This evidence concerns the gene LPA and congenital bilateral aplasia of vas deferens from CFTR mutation.